IPMN

(redirected from Intraductal Papillary Mucinous Neoplasms)
AcronymDefinition
IPMNIntraductal Papillary Mucinous Neoplasms (pancreatic cancer)
IPMNInternational Public Management Network
IPMNIntegrated Pest Management Network
IPMNInhalable Particulate Monitoring Network (US EPA)
IPMNInteractive Protocol for Mobile Networks
IPMNIntermediate Pre-Manufacture Notice
References in periodicals archive ?
Intraductal papillary mucinous neoplasms with the intestinal or pancreatobiliary subtypes are more likely to harbor an associated invasive PDAC, whereas purely gastric IPMNs are the least likely to have an associated invasive malignancy.
Secondly, intraductal papillary mucinous neoplasms (IPMNs) are macroscopic lesions, which occur in about 2% of all adults, rising to about 10% by age 70, and have about a 25% risk of developing into invasive cancer.
We previously reported that tumor vascularity visualized on CE-EUS enabled differentiation of mural nodules from mucous clots in intraductal papillary mucinous neoplasms of the pancreas [8] and prediction of chemotherapy efficacy in PC patients [9].
9) Although serous cystadenomas (35%), mucinous cystic cystadenomas (25%) and intraductal papillary mucinous neoplasms (15%) are the cystic pancreatic tumours most commonly encountered in clinical practice, this category also includes rare SPENs of the pancreas.
Imaging technologies currently are sensitive enough to identify intraductal papillary mucinous neoplasms but are insufficient for detecting PanIN lesions.
The team led by Dr Hwyda Arafat, associate professor of Surgery at Jefferson Medical College of Thomas Jefferson University, analyzed the MCP-1 levels in serum samples obtained from patients with confirmed PDA or intraductal papillary mucinous neoplasms (IPMN).
Intraductal papillary mucinous neoplasms often have a prominent papillary epithelial architecture, which is typically not seen in simple mucinous cysts or MCNs.
Intraductal tubulopapillary neoplasms of the pancreas distinct from pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms.
4) The WHO classification applies the similar grading scheme of pancreatic intraductal papillary mucinous neoplasms (IPMN) to IPN-B and divides it into 2 groups on the basis of architectural and cellular atypia: IPN-B with low or intermediate dysplasia, and IPN-B with high-grade dysplasia.
Intraductal papillary mucinous neoplasms are typically cystic, have more abundant mucin, and their architecture is predominantly papillary.